Since nitroglycerin has no negative chronotropic activity itself [5], the decrease in heart rate at maximum workload (p < 0.05) as well as the reduction in exercise induced increase in heart rate (p<0.01) must be due to decreased ...
Author: Bodo E. Strauer
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 9783110898262
Category: Medical
Page: 125
View: 624
NOC 2001-2005 01 Transderm - Nitro 5 to large fluctuations in the plasma concentration profile when conventional dosage forms of nitroglycerin , such as the sub lingual tablets , are ingested , as evidenced in Figure 5.
Author:
Publisher:
ISBN: UCLA:31158012789425
Category: Medical care
Page: 439
View: 221
Corotid pulse Control Nitroglycerin lmin Nitroglycerin 5 mins _ 100 can r E |\so |\\ E Ob 5 un un |-- 3. 1 sec 1 sec 1 sec sil 0 - Rodial pulse Control Nitroglycerin 1min Nitroglycerin 5 mins – 100 cr) T E E 3. -] % H H 3.
Author: P. G. Hugenholtz
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 9783110870565
Category: Medical
Page: 103
View: 886
5 mg . Tablets Loestrin 211 / 20 ( Parke Davis ) 421 , 1618 Natalins Tablets ( Mead ( Rhone - Poulenc ) . . . . . . 1744 Loestrin 21 1 . ... 1637 NITROGLYCERIN INTRAVENOUS lodo - Niacin Tablets ( Forest Norlutate ( Parke - Davis ) .
Author: Edward R. Barnhart
Publisher: PDR Network
ISBN: 0874897092
Category: Drugs
Page: 2474
View: 630
With more than 1,600 color grids, this year's edition of the 40-year bestseller is comprised of 2,000 pages of detailed information on nearly 3,000 drugs. Product illustration drawings have been added as a new feature.Immediately after the 24 - hour measurement , NTG ( nitroglycerin 5 mg / ml , diluted to 1 mg / ml in saline ) was infused into a peripheral vein , using an infusion pump and an NTG - resistant infusion set .
Author: H. C. Mehmel
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 9783110821284
Category: Medical
Page: 185
View: 664
5 mg of buccal nitroglycerin . Diameters of left and right coronary arteries were measured at the same anatomic site by an unbiased observer . The film was projected on a screen at a distance of 100 cm . In three of these patients ...
Author: Anthony Aaron Joseph Goldberg
Publisher: Grune & Stratton
ISBN: UOM:39015017913131
Category: Medical
Page: 185
View: 456
Ettective date 81 - 07 - 2 94 - 59 - 7 7782 - 49 - 2 7440 - 22 - 4 100 - 42 - 5 96 - 09 - 3 7664 - 93 - 9 79 - 34 - 5 127 - 18 - 4 01 / 01 / 87 01 / 01 / 87 01 / 01 / 87 01 / 01 / 87 01 / 01 / 87 01 / 01 ... 5 - Nitro - o - anisidine .
Author:
Publisher: Pennwell Books
ISBN: UOM:39015029714014
Category: Chemicals
Page: 275
View: 376
This workbook is useful for any company required to report under the Emergency Planning and Community Right to Know Act. It sets forth standards enabling the reader to decided if he or she needs to report, and if so, shows how to report.Improvements in Production and Application of Guneotton, (5-1:. {C'Q'Qfifig'gffg'gb Efi'ect 0f Radiations on the Brush Discharge. H igh-potential Primary. r52 IMPROVEMENTS IN PRODUCTION AND APPLICATION OF GUNCOTTON AND NITROGLYCERIN.
Author: William Crookes
Publisher:
ISBN: PSU:000067434855
Category: Chemistry
Page:
View: 650
Table 9.2 Different Nitrate Preparations and Dosages Medication Usual Dose (mg) Onset of Action (min) Duration of Action Short-acting Sublingual nitroglycerin 0.3-0.6 2-5 10-30 min Aerosol nitroglycerin 0.4 2-5 10-30 min Sublingual and ...
Author: Wilbert S. Aronow
Publisher: CRC Press
ISBN: 9781842145432
Category: Medical
Page: 800
View: 196
With advances and breakthroughs in modern medicine that are allowing people to live longer, the number of older adults will continue to grow exponentially over the next several decades. Cardiologists, geriatricians, and other clinicians caring for the elderly will require—at the very least—a basic understanding of cardiovascular disorders that commonly affect the older patient. In the fifth edition of Tresch and Aronow's Cardiovascular Disease in the Elderly, each chapter has been thoroughly updated to provide a comprehensive, yet accessible overview of the epidemiology, pathophysiology, evaluation, and treatment of cardiovascular disorders in older adults. The book spans topics such as aging changes in the cardiovascular system, risk factors and epidemiology for coronary artery disease, valvular heart disease, cardiomyopathies and heart failure, arrhythmias, cerebrovascular disease, and other miscellaneous subjects. The contributors supply evidence-based recommendations with strong emphasis on new research findings. New to the Fifth Edition: Numerous chapters comprehensively revised with new authors and/or co-authors Summaries at the beginning of each chapter to facilitate easy reading Discussion of the use of new antithrombotic agents in older adults Important references in the bibliography highlighted for simplified access With contributions from recognized experts in the field, this classic work continues to serve as the premier source on the evaluation and management of cardiovascular disorders in older adults.